Monday, September 29, 2014 9:10:25 AM
Looking at a huge potential for the future of PSDV.
3 FDA approvals
25 mil payment w/ sales already in EU
The increase in revenue will speed up their incredible pipeline.
The potential with Tethadur is a monster
I would not be surprised to see a buyout from a large phrama
3 FDA approvals
25 mil payment w/ sales already in EU
The increase in revenue will speed up their incredible pipeline.
The potential with Tethadur is a monster
I would not be surprised to see a buyout from a large phrama
Recent EYPT News
- EyePoint Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/19/2026 11:00:00 AM
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/18/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:26:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 11:05:16 AM
- EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data • GlobeNewswire Inc. • 05/14/2026 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:06:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:05:19 AM
- EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 08:08:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 08:05:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 08:07:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/17/2026 08:36:59 PM
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/16/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 08:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 08:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:31:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 08:12:55 PM
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/16/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:32:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:06:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:02:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 12:05:26 PM
